BioPivot logo

BioPivot Review

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10

Best for: people who want posted prices for compounded semaglutide, tirzepatide or microdosing before an intake

7.2
★★★★☆7.2/10

BioPivot scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $168 a month; its compounded semaglutide, at $218, is 10% above the $199 median among the sellers we compare.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

$168/mo

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Charged on top

Coaching

Not stated

See plans →

Prices checked November 2026

Compare top-rated alternatives ↓

BioPivot is a Phoenix telehealth brand that sells compounded semaglutide and tirzepatide, including lower-dose microdosing plans, plus sermorelin, NAD+, glutathione and PT-141. Elite Care Health, an independent physician group, prescribes, and Rx Ave Health fills the prescriptions. Monthly plans run $185 to $225 for semaglutide and $242 to $350 for tirzepatide, with microdosing from $168, and every plan price is posted before you start.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
GLP-1 from $168/moPrice shown up frontIncludes medication + consultPharmacy namedNo FDA warning letters found

Is BioPivot legit?

Yes. BioPivot is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 7.2/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.

Is there a BioPivot promo or coupon code?

We know of no promo or coupon code for BioPivot. Its listed price is $168 a month. Coupon sites advertising "BioPivot discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.

See how BioPivot compares on our rankings of the best semaglutide providers and the best tirzepatide providers.

Vetted alternatives to BioPivot

9.3/ 10
Verified partner

Embody

Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies

★★★★★9.3/10

Editorial score · methodology

$79/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full Embody review →
8.7/ 10
Verified partner

Eden

Best for: coverage in all 50 states, which most sellers will not confirm

★★★★☆8.7/10

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideGHK-CuGlutathione
Get StartedRead full Eden review →
6.6/ 10
Verified partner

HumeCare+

Best for: an oral route if you will not self-inject

★★★☆☆6.6/10

Editorial score · methodology

$199/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full HumeCare+ review →
BioPivot logo
7.2 / 10
Our editorial rating
Visit BioPivot →

from $168/mo · no insurance needed

BioPivot at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$168/mo
What's included
Medication · Consult · Shipping
FDA status
No FDA warning letters found

How BioPivot scores

Six columns, each one computed from something BioPivot has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.

Value25%

4.3/10

$218/month is 10% above the $199 median for compounded semaglutide across the sellers we compare. A cheaper starter or microdose price is also listed; Value is scored on the standard dose.

Effectiveness25%

10.0/10

Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).

User Experience15%

8.0/10

A price is shown before the questionnaire starts.

Trust & Safety15%

8.0/10

It names the pharmacy that fills its prescriptions. It shows a price before asking for health information.

Accessibility10%

5.0/10

No state list is available to check, so this is held at the midpoint rather than scored on reach.

Support10%

7.0/10

The price covers the medication, clinician visits and shipping.

6weighted dimensions
734sellers compared
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →

What we checked on BioPivot

Last checked November 2026
  • Checked the listed price across 8 dose or plan tiers
  • Checked what the monthly price covers, and what it leaves out
  • Recorded which pharmacies the seller names as filling its prescriptions, with the page and date
  • Checked FDA warning letters for BioPivot

Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.

What signing up with BioPivot involves

What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.

  1. 1BioPivot shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
  2. 2Rx Ave Health fills the prescriptions, and BioPivot names it publicly, which most sellers do not.
  3. 3The monthly price includes the medication, clinician visits and shipping.
Price shown before you start
  • Lowest ongoing monthly price: semaglutide $168, tirzepatide $220. That leaves out membership fees, first-month rates and insurance copays.
  • Confirm that BioPivot serves your state before you start.
  • The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.

Contacting BioPivot

Email
BioPivot offers email support
Hours
Monday-Friday, 9:00 AM-5:00 PM (time zone not stated)

Cancelling BioPivot

Taken from the terms BioPivot publishes. Terms change, so check the current policy before you subscribe.

Cancel any time
Yes
Minimum commitment
Monthly plans renewing every 30 days, or quarterly plans; the cancellation policy describes a 3-month membership
Refund policy
Full refund before a provider reviews your intake; after review the $59 doctor consultation fee is kept, including when you are not approved; shipped compounded medication is final sale

Medications BioPivot lists

BioPivot lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.

Peptides BioPivot offers

BioPivot sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.

Pricing

Prices re-verified

Starter plan, monthly (renews every 30 days)Compounded
$185/mo
semaglutide

Quarterly option listed at $400 (about $133/mo); whether that is one charge was not confirmed because the cart was not reached. Code BIOPIVOT20 takes 20% off the first order.

Continuation plan, monthly (renews every 30 days)Compounded
$218/mo
semaglutide

Quarterly option listed at $490 (about $163/mo).

Maintenance plan, monthly (renews every 30 days)Compounded
$225/mo
semaglutide

Quarterly option listed at $518 (about $173/mo).

Microdosing plan (lower dose), monthly (renews every 30 days)Compounded
$168/mo
semaglutide

Quarterly option listed at $370 (about $123/mo). Sold as the GLP-1 Microdose program, 500 mcg/mL.

Starter plan, monthly (renews every 30 days)Compounded
$242/mo
tirzepatide

Quarterly option listed at $590 (about $197/mo); whether that is one charge was not confirmed. Code BIOPIVOT20 takes 20% off the first order.

Continuation plan, monthly (renews every 30 days)Compounded
$315/mo
tirzepatide

Quarterly option listed at $780 (about $260/mo).

Maintenance plan, monthly (renews every 30 days)Compounded
$350/mo
tirzepatide

Quarterly option listed at $900 ($300/mo).

Microdosing plan (lower dose), monthly (renews every 30 days)Compounded
$220/mo
tirzepatide

Quarterly option listed at $528 (about $176/mo).

Check the price yourself before you pay

Every figure here comes from BioPivot's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.

See BioPivot pricing →

BioPivot compounding-pharmacy partners

BioPivot names each pharmacy below as one that compounds or fills its prescriptions, in its own site, terms or filings. The quote under each one is the seller’s own wording.

Rx Ave Health

“Who handles pharmacy and prescription fulfillment? Rx Ave Health: [email], (833) 360-4276”

Compare every compounding pharmacy we’ve reviewed →

In its favor

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping
  • Names Rx Ave Health as the pharmacy that fills its prescriptions, which most sellers do not
  • We found no FDA warning letters issued to BioPivot

Against it

  • Semaglutide costs $218 a month, 10% above the $199 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $315 a month, 17% above the $269 median for compounded tirzepatide across the sellers we compare
  • Not included in the monthly price: lab work
  • Confirm it serves your state before you start the intake
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

What BioPivot charges

The standing price at BioPivot is $168/month.

  • Compounded semaglutide (30-day starter): $185/month
  • Compounded semaglutide (30-day, continuation plan): $218/month
  • Compounded semaglutide (30-day, maintenance plan): $225/month
  • Compounded semaglutide (microdose, 30-day): $168/month
  • Compounded tirzepatide (30-day starter): $242/month
  • Compounded tirzepatide (30-day, continuation plan): $315/month

For compounded semaglutide, the median across the sellers we compare is $199/month, so BioPivot's $218 lands mid-market. Price is unlikely to be the deciding factor. Before you pay, compare BioPivot's cancellation terms with other sellers' cancellation and refund policies.

HealthRX dispenses semaglutide and tirzepatide from $165/month, which makes it the fair comparison to run before you commit here.

What BioPivot dispenses

BioPivot prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy. BioPivot also lists a microdose plan, and the published evidence on GLP-1 microdosing is letters and commentary rather than trials.

Safety and disclosure

BioPivot tells you its price before you start the medical questionnaire and the pharmacy that fills its prescriptions. We found no FDA warning letters issued to BioPivot. Because the medication is compounded, the named pharmacy is the detail that matters most: its license is the one you can look up. The FDA publishes seven warning signs for telehealth medicine sellers, and they take a minute to run against BioPivot. How we weigh oversight, disclosure and price is set out in our scoring methodology.

BioPivot also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.

Who should look elsewhere

  • You want the FDA-approved pen specifically. Everything listed here is compounded.
  • You need insurance to cover the cost. Check whether BioPivot bills your plan before you start.

Our read

BioPivot lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits you. MEDGm is the nearest comparison we review, and worth reading alongside this.

The Bottom Line

BioPivot scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $168 a month; its compounded semaglutide, at $218, is 10% above the $199 median among the sellers we compare.

Score: 7.2/10Best for: people who want posted prices for compounded semaglutide, tirzepatide or microdosing before an intakeFrom: $168/mo

Before you pay BioPivot

Starting at $168 a month. Check today's price, then start the intake.

Where BioPivot is the wrong choice

No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.

  • If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
  • If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
  • If you want a human checking in, not just a prescription, consider Eden.

If none of these fits, our guide to alternatives to BioPivot sets more sellers in the same category beside BioPivot on price, states and what the price includes.

Frequently Asked Questions

BioPivot is a Phoenix telehealth brand that sells compounded semaglutide and tirzepatide, including lower-dose microdosing plans, plus sermorelin, NAD+, glutathione and PT-141. Elite Care Health, an independent physician group, prescribes, and Rx Ave Health fills the prescriptions. Monthly plans run $185 to $225 for semaglutide and $242 to $350 for tirzepatide, with microdosing from $168, and every plan price is posted before you start. We rate it 7.2/10 overall.
BioPivot starts at $168 a month, but that is for its microdose tier; its standard injectable starts at $218. The pricing table above lists every tier.
Ask BioPivot whether it serves your state before you start the intake, and get the answer in writing.
BioPivot lists compounded semaglutide and compounded tirzepatide.
BioPivot lists compounded GLP-1s only. A licensed compounding pharmacy prepares them: same active ingredient as the brand drug, lower cash price, and no FDA approval of the finished product. That last part is the one readers underestimate, and the review above says why.
Check whether BioPivot bills your insurance before you sign up. Compounded GLP-1s are rarely covered by insurance, so plan on paying the listed cash price.
BioPivot says the price covers medication, the clinician visit and shipping. Lab work is billed on top. The strip near the top of this review shows what is included and what is not.
You fill in an online intake, a licensed clinician decides whether a GLP-1 is appropriate, and if the answer is yes the medication ships to you. BioPivot runs that whole sequence on its own site.
We found no FDA warning letters issued to BioPivot. Before you buy, weigh these: Semaglutide costs $218 a month, 10% above the $199 median for compounded semaglutide across the sellers we compare. Tirzepatide costs $315 a month, 17% above the $269 median for compounded tirzepatide across the sellers we compare. Not included in the monthly price: lab work. None of them rules BioPivot out, but each is worth settling before you pay.
Other sellers we cover include MEDGm, HealthRX, and MyDrHank. Which one fits depends on the medication, the monthly price you can sustain and whether it ships to your state, so compare those three facts before you switch.

How to check BioPivot yourself

Glossary

The words sellers use, defined. Tap any term.

Sources

Cited across this BioPivot review: primary regulatory filings, and peer-reviewed studies.

Sources & methodology — as of November 2026
  1. 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.

See BioPivot's current pricing

Plans start at $168 a month. Whether you qualify is a clinician's decision, made after your intake.